Syndrome X

Syndrome X may refer to: Cardiac syndrome X Cardiac syndrome X is angina (chest pain) with signs associated with decreased blood flow to heart tissue but with normal coronary arteries. Some stud...

Nifedipine-Maintained Tocolysis Doesn't Alter Birth Outcomes

Maintenance tocolysis with nifedipine beyond 48 hours does not reduce adverse perinatal outcomes, according to a new randomized controlled trial. Medscape Medical News

Human medicines European Public Assessment Report (EPAR): Telmisartan Actavis, telmisartan, Revision: 2, Authorised

Pending EC decision: Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Opinion date: 25-Apr-2013

Human medicines European Public Assessment Report (EPAR): Telmisartan Teva, telmisartan, Revision: 3, Authorised

Human medicines European Public Assessment Report (EPAR): Telmisartan Teva Pharma, telmisartan, Revision: 1, Authorised

Human medicines European Public Assessment Report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Revision: 20, Authorised

Human medicines European Public Assessment Report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Revision: 19, Authorised

Nifedipine-maintained tocolysis no benefit in perinatal outcomes

(HealthDay)—For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study publishe...

Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice.

The protective effect of telmisartan, the angiotensin II-receptor antagonist, against liver toxicity induced by sodium arsenite (5 mg/kg/day, p.o., for 30 days) was investigated in mice. Telmisartan t...

First automatic radiosynthesis of (11)C labeled Telmisartan using a multipurpose synthesizer for clinical research use.

OBJECTIVE: Telmisartan, a nonpeptide angiotensin II AT1 receptor antagonist, is an antihypertensive drug. Positron emission tomography (PET) imaging with [(11)C]Telmisartan is expected to provide info...

The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action.

Telmisartan is an angiotensin II receptor blocker and partial peroxisome proliferator-activated receptor gamma agonist that modulates the renin-angiotensin-aldosterone system. It is used primarily to...

Dynamic Analysis of GI Absorption and Hepatic Distribution Processes of Telmisartan in Rats Using Positron Emission Tomography.

PURPOSE: To dynamically analyze the processes of oral absorption and hepatobiliary distribution of telmisartan using positron emission tomography (PET). METHODS: (11)C-labeled telmisartan ([(11)C]TEL)...

A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic.

Objective. To characterize the pharmacokinetics of nifedipine when used for tocolysis in preterm labor and to determine the impact of genetics on these parameters. Study design. Pharmacokinetic st...